BMY - BRISTOL MYERS SQUIBB CO
62.33
1.110 1.781%
Share volume: 12,306,233
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$61.22
1.11
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 04-25-2024 | 07-26-2024 | 10-31-2024 | 02-12-2025 | 04-24-2025 | 07-31-2025 | 10-30-2025 | 02-11-2026 | |
| Total revenue | 11.865 B | 12.201 B | 11.892 B | 12.342 B | 11.201 B | 12.269 B | 12.222 B | 12.502 B | |
| Cost of revenue | 15.881 B | 3.399 B | 3.219 B | 4.842 B | 3.221 B | 4.880 B | 4.068 B | 5.488 B | |
| Gross profit | -4.016 B | 8.802 B | 8.673 B | 7.500 B | 7.980 B | 7.389 B | 8.154 B | 7.014 B | |
| 319.17% | -1.47% | -13.52% | 6.40% | -7.41% | 10.35% | -13.98% | |||
| Operating expenses | 5.062 B | 4.827 B | 4.357 B | 5.327 B | 3.841 B | 4.293 B | 4.317 B | 4.767 B | |
| Selling general and admin | 2.367 B | 1.928 B | 1.983 B | 2.136 B | 1.584 B | 1.713 B | 1.789 B | 2.181 B | |
| Research and development | 2.695 B | 2.899 B | 2.374 B | 3.191 B | 2.257 B | 2.580 B | 2.528 B | 2.586 B | |
| Total expenses | 7.419 B | 7.243 B | 6.763 B | 7.020 B | 4.671 B | 5.123 B | 5.148 B | 5.593 B | |
| -2.37% | -6.63% | 3.80% | -33.46% | 9.68% | 0.49% | 8.64% | |||
| Operating income | -11.435 B | 1.559 B | 1.910 B | 480.000 M | 3.309 B | 2.266 B | 3.006 B | 1.421 B | |
| Ebit | -11.516 B | 1.286 B | 1.676 B | 175.000 M | 2.970 B | 1.772 B | 3.114 B | 1.472 B | |
| Pretax income | -11.516 B | 1.286 B | 1.676 B | 175.000 M | 2.971 B | 1.773 B | 3.114 B | 1.470 B | |
| -111.17% | 30.33% | -89.56% | 1,597.71% | -40.32% | 75.63% | -52.79% | |||
| Income tax | 392.000 M | -398.000 M | 461.000 M | 99.000 M | 509.000 M | 460.000 M | 919.000 M | 384.000 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -11.908 B | 1.684 B | 1.215 B | 76.000 M | 2.462 B | 1.313 B | 2.195 B | 1.085 B | |
| 114.14% | -27.85% | -93.74% | 3,139.47% | -46.67% | 67.17% | -50.57% |